BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32086528)

  • 41. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
    Mallm JP; Iskar M; Ishaque N; Klett LC; Kugler SJ; Muino JM; Teif VB; Poos AM; Großmann S; Erdel F; Tavernari D; Koser SD; Schumacher S; Brors B; König R; Remondini D; Vingron M; Stilgenbauer S; Lichter P; Zapatka M; Mertens D; Rippe K
    Mol Syst Biol; 2019 May; 15(5):e8339. PubMed ID: 31118277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GATA-1-dependent histone H3K27 acetylation mediates erythroid cell-specific chromatin interaction between CTCF sites.
    Kim YW; Kang Y; Kang J; Kim A
    FASEB J; 2020 Nov; 34(11):14736-14749. PubMed ID: 32924169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
    Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
    Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
    [No Abstract]   [Full Text] [Related]  

  • 44. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.
    Kubo N; Ishii H; Xiong X; Bianco S; Meitinger F; Hu R; Hocker JD; Conte M; Gorkin D; Yu M; Li B; Dixon JR; Hu M; Nicodemi M; Zhao H; Ren B
    Nat Struct Mol Biol; 2021 Feb; 28(2):152-161. PubMed ID: 33398174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A CTCF-binding site in the Mdm1-Il22-Ifng locus shapes cytokine expression profiles and plays a critical role in early Th1 cell fate specification.
    Liu C; Nagashima H; Fernando N; Bass V; Gopalakrishnan J; Signorella S; Montgomery W; Lim AI; Harrison O; Reich L; Yao C; Sun HW; Brooks SR; Jiang K; Nagarajan V; Zhao Y; Jung S; Phillips R; Mikami Y; Lareau CA; Kanno Y; Jankovic D; Aryee MJ; Pękowska A; Belkaid Y; O'Shea J; Shih HY
    Immunity; 2024 May; 57(5):1005-1018.e7. PubMed ID: 38697116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.
    Bornschein S; Demeyer S; Stirparo R; Gielen O; Vicente C; Geerdens E; Ghesquière B; Aerts S; Cools J; de Bock CE
    Leukemia; 2018 Apr; 32(4):941-951. PubMed ID: 29151585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variable Extent of Lineage-Specificity and Developmental Stage-Specificity of Cohesin and CCCTC-Binding Factor Binding Within the Immunoglobulin and T Cell Receptor Loci.
    Loguercio S; Barajas-Mora EM; Shih HY; Krangel MS; Feeney AJ
    Front Immunol; 2018; 9():425. PubMed ID: 29593713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
    Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
    Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancer release and retargeting activates disease-susceptibility genes.
    Oh S; Shao J; Mitra J; Xiong F; D'Antonio M; Wang R; Garcia-Bassets I; Ma Q; Zhu X; Lee JH; Nair SJ; Yang F; Ohgi K; Frazer KA; Zhang ZD; Li W; Rosenfeld MG
    Nature; 2021 Jul; 595(7869):735-740. PubMed ID: 34040254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequential in
    Amândio AR; Beccari L; Lopez-Delisle L; Mascrez B; Zakany J; Gitto S; Duboule D
    Genes Dev; 2021 Nov; 35(21-22):1490-1509. PubMed ID: 34711654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
    Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
    Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
    Eldholm V; Haugen A; Zienolddiny S
    Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissection of a CTCF topological boundary uncovers principles of enhancer-oncogene regulation.
    Kim KL; Rahme GJ; Goel VY; El Farran CA; Hansen AS; Bernstein BE
    Mol Cell; 2024 Apr; 84(7):1365-1376.e7. PubMed ID: 38452764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions.
    Lee J; Krivega I; Dale RK; Dean A
    Cell Rep; 2017 Jun; 19(12):2490-2502. PubMed ID: 28636938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.
    Dhami P; Bruce AW; Jim JH; Dillon SC; Hall A; Cooper JL; Bonhoure N; Chiang K; Ellis PD; Langford C; Andrews RM; Vetrie D
    PLoS One; 2010 Feb; 5(2):e9059. PubMed ID: 20140202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia.
    Lim FQ; Chan AS; Yokomori R; Huang XZ; Theardy MS; Yeoh AEJ; Tan SH; Sanda T
    Haematologica; 2023 Feb; 108(2):367-381. PubMed ID: 36073513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The 5' boundary of the human apolipoprotein B chromatin domain in intestinal cells.
    Antes TJ; Namciu SJ; Fournier RE; Levy-Wilson B
    Biochemistry; 2001 Jun; 40(23):6731-42. PubMed ID: 11389587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic Marks Associated with Chromatin Compartments in the CTCF, RNAPII Loop and Genomic Windows.
    Szczepińska T; Mollah AF; Plewczynski D
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. S1P-S1PR3-RAS promotes the progression of S1PR3
    Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
    Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CTCF-Mediated Enhancer-Promoter Interaction Is a Critical Regulator of Cell-to-Cell Variation of Gene Expression.
    Ren G; Jin W; Cui K; Rodrigez J; Hu G; Zhang Z; Larson DR; Zhao K
    Mol Cell; 2017 Sep; 67(6):1049-1058.e6. PubMed ID: 28938092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.